Clinical Experience
As a CRO with more than 20 years of experience gained in almost all therapeutic areas, we guarantee a high know-how to manage activities of specific pathologies
Over the years GB Pharma has been involved in more than 200 clinical projects gaining experience in almost all Therapeutic Areas and study designs. Our experience and expertise is not limited to Pharmaceuticals, that represent the greatest part of our experience, but also extended to Medical Devices and Food Supplements. Additionally, the experience and expertise of GB Pharma is enriched by a staff of qualified clinical and regulatory professionals with significant activity in the biomedical and pharmaceutical Industry.
Click on the bottom below to find more about our experience:
Therapeutic areas
Oncology
Advanced solid tumors; Breast cancer; Ependymoma; Epithellial ovarian cancer, fallopian cancer, primary peritoneal cancer; Gastroenteropancreatic and thoracic neuroendocrine tumour; Glioblastoma Hematologic malignancies; Hepatocellular carcinoma; Hodking’s linfoma; Multiple Myeloma; Non small cell lung cancer; Ovarian cancer; Pain from cancer; Pheochromocytomas; Pleural Mesothelioma; POEMS syndrome; Prostate cancer; Renal Carcinoma; Sanfilippo B phase syndrome; Soft tissue sarcoma; Solid tumors; Stomach cancer; Systemic mastocitosi; T-cell lymphoma
Cardiovascular / Cardiology
- Angina
- Atrial fibrillation
- Coronary Artery Disease
- Coronary lesions
- Hearth failure
- Primary Prevention of Sudden Cardiac Arrest
syncope - Ultrafiltration treatment in patients with advanced volume overload
- Ventricular hypertrophy
- LDL cholesterol decrease
- Venous Thromboembolism
- lower limb varicose veins
- Cardiovascular events
Neurology
- Amiloidosis
- Chronic migraineChronic migraine
- Crisis Post Stroke
- Intracranial aneurysms treatment
- Multi-Infarct Dementia
- Multiple Sclerosis
- Parkinson
- Spinal muscolar atrophy
Infectious Diseases
- COVID-19
- HIV
- Intensive care Unit
Immunology
- Encephalitis Virus – Vaccine
- Hepatitis B
- Hereditary angioedema
- Idiopathic angioedema
- Kidney Transplantation
- Liver Transplantation
- Organ transplant
- Renal transplant recipients
- Rheumatoid Arthritis
- Paediatric hereditary angioedema
Gastroenterology
- Crohn’s Disease
- Gastroesophageal reflux
- Inflammatory bowel disease
- Irritable bowel syndrome
- Pouchitis
- Ulcerative Colitis
- primary
sclerosing cholangitis
Urology / Nephrology
- Bacterial Vaginosis
- Erectile failure;
- Interstitial Cystitis
- Overactive Bladder
- Premature Ejaculation
- Preterm birth
- Recurrent bacterial cystitis
- Paediatric ESRD patients
- Dialysis
- Sclerosing encapsulating peritonitis
- Kidney disease
Musculoskeletal Disorders / Orthopedics / Rheumatology
- Articular cartilage lesions of the knee
- Arthroscopy
- Bioavailability
- Degenerative cervical disc
- Knee replacement surgery
- Osteoporosis
- Pain from Osteoarthritis
- Spondyloarthritis
- Juvenile Idiopathic Arthritis
- Fibromyalgia
Respiratory Tract Diseases
- Asthma and COPD
- BPCO
- Bronchial Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic fibrosis
- Idiopathic Pulmonary Fibrosis
- Lower Respiratory Tract Infections
- Pulmonary arterial hypertension
Dermatology
- Acne
- Alopecia areata
- Atopic Dermatitis
- Facial hirsutism
- Herpes Simplex Labialis
- Hyperhidrosis
- Pityriasis versicolor
- Scabies
- Scalp psoriasi
Contrast means
Contrast media
Endocrinology / Metabolic disorder / nutritional support
- Acromegaly
- Amyloidosis
- Testosterone deficiency
- milk for infants
- PKU
- Gorwth Hormone Deficiency in Children
- Metabolic syndome
- Type II diabetes
- Obesity
Psychiatry and Psychology
- Alcohol abuse
- Schizophrenia
- Bipolar disorder
- Mental disorder
Others
- Allergology
- Hematology
- Opthalmology
- Pregnancy and ginaecology
- odontostomatology
Pharmaceuticals
Early Phase Development
Our early phase experience represents the 40 % of our overall experience with pharmaceuticals. Our experience encompasses Phase I, Phase II, Phase IIa, Phase IIb trials, as well as BE/BA studies.
Registrative studies
We have been involved in managing roughly 50 Phase III trials.
Late Phase development
Our late-phase development experience encompasses post-marketing clinical trials (Phase IV) and Non Interventional trials. We have experience in applying different observational and epidemiological methods and design (Cohort and Case Control studies, Cross Sectional studies, Case Series, hybrid design)
Medical devices
Our experience
Over the last years we have increased our experience in managing both clinical investigations and PCMF (post-market clinical follow-up) studies with Medical Devices. With roughly 20 clinical projects managed, our main experience is focused in Cardiology / Cardiovascular.
Our experience with Medical Device is increasing and thanks with the sinergy with our Regulatory Department we provide a mix of high-added value services for the collection and generation of clinical data related to your Medical Devices.
Our experience
Over the last years we have increased our experience in managing both clinical investigations and PCMF (post-market clinical follow-up) studies with Medical Devices. With roughly 20 clinical projects managed, our main experience is focused in Cardiology / Cardiovascular.
Our experience with Medical Device is increasing and thanks with the sinergy with our Regulatory Department we provide a mix of high-added value services for the collection and generation of clinical data related to your Medical Devices.
Our experience
Over the last years we have increased our experience in managing both clinical investigations and PCMF (post-market clinical follow-up) studies with Medical Devices. With roughly 20 clinical projects managed, our main experience is focused in Cardiology / Cardiovascular.
Our experience with Medical Device is increasing and thanks with the sinergy with our Regulatory Department we provide a mix of high-added value services for the collection and generation of clinical data related to your Medical Devices.
Our experience
Over the last years we have increased our experience in managing both clinical investigations and PCMF (post-market clinical follow-up) studies with Medical Devices. With roughly 20 clinical projects managed, our main experience is focused in Cardiology / Cardiovascular.
Our experience with Medical Device is increasing and thanks with the sinergy with our Regulatory Department we provide a mix of high-added value services for the collection and generation of clinical data related to your Medical Devices.
Our experience
Over the last years we have increased our experience in managing both clinical investigations and PCMF (post-market clinical follow-up) studies with Medical Devices. With roughly 20 clinical projects managed, our main experience is focused in Cardiology / Cardiovascular.
Our experience with Medical Device is increasing and thanks with the sinergy with our Regulatory Department we provide a mix of high-added value services for the collection and generation of clinical data related to your Medical Devices.
Our experience
Over the last years we have increased our experience in managing both clinical investigations and PCMF (post-market clinical follow-up) studies with Medical Devices. With roughly 20 clinical projects managed, our main experience is focused in Cardiology / Cardiovascular.
Our experience with Medical Device is increasing and thanks with the sinergy with our Regulatory Department we provide a mix of high-added value services for the collection and generation of clinical data related to your Medical Devices.
Food supplements
Our experience
Over the last year we have been increasing our experience and expertise in managing clinical studies with Medical and Food supplements.
We have been building solid partnerships and with European Key Opinion Leaders in the a fasting growing and promising field of GUT Microbiota.
Our experience
Over the last year we have been increasing our experience and expertise in managing clinical studies with Medical and Food supplements.
We have been building solid partnerships and with European Key Opinion Leaders in the a fasting growing and promising field of GUT Microbiota.
Our experience
Over the last year we have been increasing our experience and expertise in managing clinical studies with Medical and Food supplements.
We have been building solid partnerships and with European Key Opinion Leaders in the a fasting growing and promising field of GUT Microbiota.
Our experience
Over the last year we have been increasing our experience and expertise in managing clinical studies with Medical and Food supplements.
We have been building solid partnerships and with European Key Opinion Leaders in the a fasting growing and promising field of GUT Microbiota.
Our experience
Over the last year we have been increasing our experience and expertise in managing clinical studies with Medical and Food supplements.
We have been building solid partnerships and with European Key Opinion Leaders in the a fasting growing and promising field of GUT Microbiota.
Our experience
Over the last year we have been increasing our experience and expertise in managing clinical studies with Medical and Food supplements.
We have been building solid partnerships and with European Key Opinion Leaders in the a fasting growing and promising field of GUT Microbiota.